Nebentan potassium

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameNebentan potassium
Drug Alias NameYM-598
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Us IncAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A